BWAY

BrainsWay Ltd. is a commercial-stage medical device company headquartered in Jerusalem, Israel, that develops and markets advanced technology for non-invasive treatment of brain disorders. The company's proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology uses magnetic fields to stimulate specific areas of the brain, offering a non-drug, non-surgical treatment option for various neurological and psychiatric conditions. BrainsWay's flagship product platform has received FDA clearance for treating major depressive disorder and obsessive-compulsive disorder, with ongoing clinical studies exploring applications for additional indications including smoking cessation, bipolar disorder, and post-traumatic stress disorder. The company markets its Deep TMS systems to healthcare providers worldwide, with a growing installed base at psychiatric and neurological treatment centers. BrainsWay combines neuroscience expertise with advanced engineering to develop evidence-based solutions that aim to improve quality of life for patients with debilitating brain disorders.